Skip to main content

Venture

VC Sofinnova ropes in €650M for biotech, medtech despite 'volatile' environment

Friday, March 27, 2026 · first reported by Fierce Biotech

Sofinnova, a prominent VC firm, has raised €650M (approximately $715M) for its biotech and medtech fund despite volatile market conditions. The fund will focus on early-stage and growth investments in the life sciences sector.

Asset class
Venture
Geography
Europe

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

More in Venture capital

From the same day

Got news? Send it to us →